ARDELYX, INC. Increase (Decrease) in Accounts Receivable
ARDELYX, INC. (ARDX) reported Increase (Decrease) in Accounts Receivable of $28.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- ARDELYX, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $17.51M, a 8.86% increase year-over-year.
- ARDELYX, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $10.99M.
- ARDELYX, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$4.76M, a 205.59% decline year-over-year.
- ARDELYX, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $14.06M, a 11.89% decline year-over-year.
- ARDELYX, INC. increase (decrease) in accounts receivable for fiscal 2025 was $14.14M, a 60.35% decline from fiscal 2024.
- ARDELYX, INC. increase (decrease) in accounts receivable for fiscal 2024 was $35.67M, a 149.50% increase from fiscal 2023.
- ARDELYX, INC. increase (decrease) in accounts receivable for fiscal 2023 was $14.30M, a 97.73% increase from fiscal 2022.
- ARDELYX, INC. increase (decrease) in accounts receivable for fiscal 2022 was $7.23M, a 1340.44% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $28.50M 10-Q · filed 2026-08-06 | $23.74M derived: sum of 3 quarters · filed 2026-08-06 | $37.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $10.99M 10-Q · filed 2026-04-30 | $6.23M derived: sum of 2 quarters · filed 2026-04-30 | $20.29M derived: sum of 3 quarters · filed 2026-04-30 | $36.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $9.29M derived: sum of 2 quarters · filed 2026-02-19 | $25.38M derived: sum of 3 quarters · filed 2026-08-06 | $14.14M 10-K · filed 2026-02-19 |
| 2025-09-30 | $14.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $30.14M derived: sum of 2 quarters · filed 2026-08-06 | $18.91M 10-Q · filed 2025-10-30 | $23.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $16.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.85M 10-Q · filed 2026-08-06 | $9.36M derived: sum of 3 quarters · filed 2026-08-06 | $25.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$11.24M 10-Q · filed 2026-04-30 | -$6.73M derived: sum of 2 quarters · filed 2026-04-30 | $9.23M derived: sum of 3 quarters · filed 2026-04-30 | $18.30M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $20.46M derived: sum of 2 quarters · filed 2026-02-19 | $29.54M derived: sum of 3 quarters · filed 2026-02-19 | $35.67M 10-K · filed 2026-02-19 |
| 2024-09-30 | $15.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $25.03M derived: sum of 2 quarters · filed 2025-10-30 | $31.16M 10-Q · filed 2025-10-30 | $9.93M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $9.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $15.21M 10-Q · filed 2025-08-04 | -$6.02M derived: sum of 3 quarters · filed 2026-02-19 | $28.13M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $6.13M 10-Q · filed 2025-05-01 | -$15.10M derived: sum of 2 quarters · filed 2026-02-19 | $19.05M derived: sum of 3 quarters · filed 2026-02-19 | $16.04M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$21.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $12.92M derived: sum of 2 quarters · filed 2026-02-19 | $9.91M derived: sum of 3 quarters · filed 2026-02-19 | $14.30M 10-K · filed 2026-02-19 |
| 2023-09-30 | $34.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $31.14M derived: sum of 2 quarters · filed 2024-10-31 | $35.53M 10-Q · filed 2024-10-31 | $38.05M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | -$3.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $1.38M 10-Q · filed 2024-08-01 | $3.90M derived: sum of 3 quarters · filed 2025-02-20 | $3.49M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $4.39M 10-Q · filed 2024-05-02 | $6.91M derived: sum of 2 quarters · filed 2025-02-20 | $6.50M derived: sum of 3 quarters · filed 2025-02-20 | $7.73M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $2.11M derived: sum of 2 quarters · filed 2025-02-20 | $3.34M derived: sum of 3 quarters · filed 2025-02-20 | $7.23M 10-K · filed 2025-02-20 |
| 2022-09-30 | -$415.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $814.00K derived: sum of 2 quarters · filed 2023-10-31 | $4.71M 10-Q · filed 2023-10-31 | $4.92M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $5.12M 10-Q · filed 2023-08-02 | $5.34M derived: sum of 3 quarters · filed 2024-02-22 | $5.62M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $3.89M 10-Q · filed 2023-05-03 | $4.11M derived: sum of 2 quarters · filed 2024-02-22 | $4.39M derived: sum of 3 quarters · filed 2024-02-22 | -$1.39M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $502.00K derived: sum of 2 quarters · filed 2024-02-22 | -$5.28M derived: sum of 3 quarters · filed 2024-02-22 | $502.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | $287.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$5.50M derived: sum of 2 quarters · filed 2022-11-03 | $287.00K 10-Q · filed 2022-11-03 | $287.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | -$5.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | |
| 2021-03-31 | $5.78M 10-Q · filed 2022-05-05 | $5.78M derived: sum of 2 quarters · filed 2023-03-02 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 10-K · filed 2023-03-02 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | -$85.00K 10-K · filed 2022-02-28 | |||
| 2018-12-31 | -$82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $55.00K derived: sum of 2 quarters · filed 2021-03-08 | $85.00K derived: sum of 3 quarters · filed 2021-03-08 | -$10.71M 10-K · filed 2021-03-08 |
| 2018-09-30 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $167.00K derived: sum of 2 quarters · filed 2018-11-07 | -$10.63M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$10.77M 10-Q · filed 2018-08-07 | ||
| 2018-03-31 | -$10.80M 10-Q · filed 2018-05-08 | |||
| 2017-12-31 | $10.80M 10-K · filed 2020-03-06 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$27.00K derived: sum of 2 quarters · filed 2018-03-14 | -$2.04M derived: sum of 3 quarters · filed 2018-03-14 | -$2.58M 10-K · filed 2018-03-14 |
| 2015-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$2.04M derived: sum of 2 quarters · filed 2016-11-07 | -$2.58M 10-Q · filed 2016-11-07 | -$2.66M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | -$2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$2.56M 10-Q · filed 2016-08-08 | -$2.63M derived: sum of 3 quarters · filed 2017-02-17 | -$3.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | -$541.00K 10-Q · filed 2016-05-09 | -$617.00K derived: sum of 2 quarters · filed 2017-02-17 | -$982.00K derived: sum of 3 quarters · filed 2017-02-17 | -$2.93M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | -$76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$441.00K derived: sum of 2 quarters · filed 2017-02-17 | -$2.39M derived: sum of 3 quarters · filed 2017-02-17 | -$3.85M 10-K · filed 2017-02-17 |
| 2014-09-30 | -$365.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$2.32M derived: sum of 2 quarters · filed 2015-11-12 | -$3.78M 10-Q · filed 2015-11-12 | -$1.67M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-06-30 | -$1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$3.41M 10-Q · filed 2015-08-12 | -$1.30M derived: sum of 3 quarters · filed 2016-03-04 | -$3.96M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-03-31 | -$1.46M 10-Q · filed 2015-05-12 | $647.00K derived: sum of 2 quarters · filed 2016-03-04 | -$2.01M derived: sum of 3 quarters · filed 2016-03-04 | |
| 2013-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | -$548.00K derived: sum of 2 quarters · filed 2016-03-04 | $3.36M 10-K · filed 2016-03-04 | |
| 2013-09-30 | -$2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.26M 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | $3.91M 10-Q · filed 2014-08-08 | |||
| 2012-12-31 | $3.07M 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |